Valine

Valine

SCHEMBL288203

CC(C)C(N)C(=O)O.CC(C)[C@H](N)C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 2/20 1.00
SLC1A3 P43003 2/20 0.48
SLC1A2 P43004 2/20 0.48
SLC1A1 P43005 2/20 0.48
TP53 P04637 1/20 0.44
LAP3 P28838 1/20 0.41
DPP4 P27487 1/20 0.41
FAP Q12884 1/20 0.41
DPP8 Q6V1X1 1/20 0.41
DPP9 Q86TI2 1/20 0.41
DPP7 Q9UHL4 1/20 0.41
USP2 O75604 1/20 0.39
SLCO1B1 Q9Y6L6 1/20 0.39
GABRP O00591 4/20 0.38
GABRD O14764 4/20 0.38
GABRA1 P14867 4/20 0.38
GABRB1 P18505 4/20 0.38
GABRG2 P18507 4/20 0.38
GABRB3 P28472 4/20 0.38
GABRA5 P31644 4/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Valine SCHEMBL29523401 1.00
Valine SCHEMBL1813972 1.00 SLC7A5 (1.00) SLC7A5SLC1A3SLC1A2SLC1A1TP53
Valine SCHEMBL29828716 1.00
Valine SCHEMBL2785563 1.00 SLC7A5 (1.00) SLC7A5SLC1A3SLC1A2SLC1A1TP53
Valine SCHEMBL43678 1.00
Valine SCHEMBL8515 1.00
Valine SCHEMBL31618928 1.00
Valine SCHEMBL41225 1.00 SLC7A5 (1.00) SLC7A5SLC1A3SLC1A2SLC1A1TP53
Valine SCHEMBL8516 1.00
Valine SCHEMBL29622105 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260137250-A1 DISPOSABLE CONTAINER FOR CONSTRUCTION-GRADE VACUUM CLEANERS HILTI AG (LI) 2026-05-21 US claimed
CN-119941951-A 3D Tiles rendering parameter tuning method 福建师范大学 2025-05-06 CN claimed
CN-119587832-A Mixed oxygen proportional valve calibration and control method 河北谊安奥美医疗设备有限公司 2025-03-11 CN claimed
CN-119402055-A Low-orbit satellite internet satellite-ground collaborative content distribution architecture service caching method 中国电子科技集团公司第五十四研究所 2025-02-07 CN claimed
CN-119053728-A Coated cutting tool 山特维克科洛曼特公司 2024-11-29 CN claimed
CN-118821428-A Encoding method and device for node number of pipeline stress analysis software 中国核电工程有限公司 2024-10-22 CN claimed
CN-117940599-A Coated cutting tool 山特维克科洛曼特公司 2024-04-26 CN claimed
EP-4090894-B1 VALVE ASSEMBLY FOR AN AIR DUCT PRADO EUROPE B V (BE) 2023-12-20 EP claimed
CN-107122524-B Method for converting pipeline mechanics analysis result into three-dimensional model 上海核工程研究设计院股份有限公司 2023-04-14 CN claimed
EP-4090894-A1 VALVE ASSEMBLY FOR AN AIR DUCT Prado Europe B.V. (BE) 2022-11-23 EP claimed
EP-3739075-B1 MAGNETIC MATERIAL FOR MAGNETIC REFRIGERATION AIST (JP) 2022-08-10 EP claimed
US-11292064-B2 Coated cutting tool and a method for coating the cutting tool SECO TOOLS AB (SE) 2022-04-05 US claimed
CN-122018641-A Hydrologic intelligent display instrument 长江水利委员会水文局汉江水文水资源勘测局(长江水利委员会水文局汉江水环境监测中心) 2026-05-12 CN disclosed
US-20260109938-A1 GENETIC CODES UNITED KINGDOM RESEARCH AND INNOVATION (GB) 2026-04-23 US disclosed
EP-4646759-A1 EXPLOSION-PROOF VENTING VALVE WITH LOCKING STRUCTURE MANN+HUMMEL GmbH (DE) 2025-11-12 EP disclosed
EP-4299969-B1 WETTING FLUID APPLICATOR AND METHOD OF APPLYING WETTING FLUID TO A PRESSURE RELIEF VALVE PLITEK LLC (US) 2025-10-22 EP disclosed
US-20110033517-A1 COATINGS FOR IMPLANTABLE MEDICAL DEVICES COMPRISING HYDROPHILIC SUBSTANCES AND METHODS FOR FABRICATING THE SAME ADVANCED CARDIOVASCULAR SYSTEMS, INC. 2011-02-10 US disclosed
WO-2010128054-A1 METHOD OF DIAGNOSING ASPHYXIA BIOCRATES LIFE SCIENCES AG (AT) 2010-11-11 WO disclosed
US-20100186590-A1 ABSORPTION MEDIUM FOR REMOVING ACID GASES WHICH COMPRISES AMINO ACID AND ACID PROMOTER BASF SE (DE) 2010-07-29 US disclosed
US-6040446-A Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative SYNTEX (U.S.A.) INC. (US) 2000-03-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260137250-A1 DISPOSABLE CONTAINER FOR CONSTRUCTION-GRADE VACUUM CLEANERS UBE2V1, UBE2T, UBE2E1 SLC7A5 3199/4885SLC1A3 4639/4885SLC1A2 4759/4885
US-20110033517-A1 COATINGS FOR IMPLANTABLE MEDICAL DEVICES COMPRISING HYDROPHILIC SUBSTANCES AND METHODS FOR FABRICATING THE SAME CD99, CD44, PUF60 SLC7A5 2316/4885SLC1A3 1979/4885SLC1A2 1602/4885
US-20260109938-A1 GENETIC CODES TRMT1L, TRMT1, TRDMT1 SLC7A5 321/4885SLC1A3 41/4885SLC1A2 88/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.